课题基金 / 基金详情

Mentoring in Translational Research in Interstitial Lung Diseases

Mentoring in Translational Research in Interstitial Lung Diseases
间质性肺疾病转化研究的指导
批准号:
10371751
负责人:
Wonder P. Drake
金额:
$11.4万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-02-15 至 2026-12-31

项目摘要

项目成果

Wonder P. Drake的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary The overall goal of this renewal application for a MidCareer Investigator Award in Patient-Oriented Research is to enable the candidate to continue to expand her research and mentoring programs in sarcoidosis patient- oriented research. This award will allow her to continue to devote significant protected time to the professional development of her current mentees with a focus on successful transition to scientific independence. During the prior award period, the candidate and her mentees identified a crucial role for the Programmed Death-1/STAT3 signaling pathway in Th17 cells to pulmonary sarcoidosis progression. Now this team provides compelling preliminary data that metformin reduces the percentage of sarcoidosis PD-1+CD4+ T cells in vitro, and that this reduction is associated with reduced human lung fibroblast (HLF) collagen production. In this renewal application, Dr. Drake and her mentees will assess the capacity of oral metformin to alter PD-1 expression on sarcoidosis CD4+ T cells in vivo, as well as identify relevant mechanisms by which this occurs. The team will determine the impact of oral metformin on sarcoidosis forced vital capacity (FVC), focus on Th17 cell immuno- metabolomic alterations, as well as alterations in STAT3 signaling. The two specific aims are as follows: 1) To assess the in vivo efficacy of oral metformin on reduction of PD-1+CD4+ T cells in sarcoidosis subjects and its impact on sarcoidosis FVC; 2) To assess if oral metformin has the capacity to reduce HLF collagen production in sarcoidosis subjects. These translational investigations will lay a firm foundation for a future advanced clinical investigation of metformin efficacy against pulmonary sarcoidosis progression. The results from the proposed clinical and mechanistic investigations will be translated into advanced clinical trials, thus providing future mentees with basic, translational and clinical platforms for their career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of sex variation in PD-1/pSTAT3/IL-17A signaling in sarcoidosis pathogenesis
Mentoring in Translational Research in Interstitial Lung Diseases
Mentoring in Translational Research in Interstitial Lung Diseases
Mentoring in Translational Research in Interstitial Lung Diseases
  • 批准号:
    10812018
  • 项目类别:
  • 资助金额:
    $11.4万
  • 财政年份:
    2016
  • 负责人:
    Wonder P. Drake
  • 依托单位:
海外基金